These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment. Brown JS, Papadopoulos G, Neumann PJ, Friedman M, Miller JD, Menzin J. Headache; 2005 Sep; 45(8):1012-22. PubMed ID: 16109115 [Abstract] [Full Text] [Related]
7. Topiramate in migraine prevention: evidence-based medicine from clinical trials. Silberstein SD. Neurol Sci; 2004 Oct; 25 Suppl 3():S244-5. PubMed ID: 15549548 [Abstract] [Full Text] [Related]
8. Cost-effectiveness of migraine prevention: the case of topiramate in the UK. Brown JS, Papadopoulos G, Neumann PJ, Price M, Friedman M, Menzin J. Cephalalgia; 2006 Dec; 26(12):1473-82. PubMed ID: 17116098 [Abstract] [Full Text] [Related]
9. Topiramate for migraine prophylaxis. Drug Ther Bull; 2006 Aug; 44(8):62-4. PubMed ID: 16903488 [Abstract] [Full Text] [Related]
10. Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials. Bussone G, Diener HC, Pfeil J, Schwalen S. Int J Clin Pract; 2005 Aug; 59(8):961-8. PubMed ID: 16033621 [Abstract] [Full Text] [Related]
11. Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety. Winner P, Gendolla A, Stayer C, Wang S, Yuen E, Battisti WP, Nye JS. Headache; 2006 Aug; 46(10):1503-10. PubMed ID: 17115983 [Abstract] [Full Text] [Related]
12. Topiramate in migraine prophylaxis: data from a pooled analysis and open-label extension study. Bussone G, Usai S, D'Amico D. Neurol Sci; 2006 May; 27 Suppl 2():S159-63. PubMed ID: 16688622 [Abstract] [Full Text] [Related]
15. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J, Topiramate Pediatric Migraine Study Investigators. Headache; 2005 Mar; 45(10):1304-12. PubMed ID: 16324162 [Abstract] [Full Text] [Related]
16. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis. Seeburger JL, Cady RK, Winner P, MacGregor A, Valade D, Ge Y, Zhang Y, Hustad CM, Strickler N, Schaefer E, Connor KM, Ho TW. Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129 [Abstract] [Full Text] [Related]
17. Topiramate in the prophylactic treatment of migraine in children. Campistol J, Campos J, Casas C, Herranz JL. J Child Neurol; 2005 Mar; 20(3):251-3. PubMed ID: 15832623 [Abstract] [Full Text] [Related]
18. A randomized, one-year clinical trial comparing the efficacy of topiramate, flunarizine, and a combination of flunarizine and topiramate in migraine prophylaxis. Luo N, Di W, Zhang A, Wang Y, Ding M, Qi W, Zhu Y, Massing MW, Fang Y. Pain Med; 2012 Jan; 13(1):80-6. PubMed ID: 22233396 [Abstract] [Full Text] [Related]
20. The effect of migraine prophylaxis on migraine-related resource use and productivity. Láinez MJ. CNS Drugs; 2009 Sep; 23(9):727-38. PubMed ID: 19689164 [Abstract] [Full Text] [Related] Page: [Next] [New Search]